- Home
- CODX vs VERB Comparison
CODX vs VERB Comparison
Compare CODX & VERB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODX
- VERB
- Stock Information
- Founded
- CODX 2013
- VERB 2014
- Country
- CODX United States
- VERB United States
- Employees
- CODX N/A
- VERB N/A
- Industry
- CODX Medical/Dental Instruments
- VERB Other Consumer Services
- Sector
- CODX Health Care
- VERB Consumer Discretionary
- Exchange
- CODX Nasdaq
- VERB Nasdaq
- Market Cap
- CODX 9.8M
- VERB 9.6M
- IPO Year
- CODX 2017
- VERB N/A
- Fundamental
- Price
- CODX $0.26
- VERB $7.11
- Analyst Decision
- CODX Buy
- VERB Strong Buy
- Analyst Count
- CODX 2
- VERB 1
- Target Price
- CODX $5.50
- VERB $62.00
- AVG Volume (30 Days)
- CODX 346.2K
- VERB 24.6K
- Earning Date
- CODX 08-07-2025
- VERB 08-13-2025
- Dividend Yield
- CODX N/A
- VERB N/A
- EPS Growth
- CODX N/A
- VERB N/A
- EPS
- CODX N/A
- VERB N/A
- Revenue
- CODX $3,497,583.00
- VERB $2,193,000.00
- Revenue This Year
- CODX N/A
- VERB $526.82
- Revenue Next Year
- CODX $42.11
- VERB $45.45
- P/E Ratio
- CODX N/A
- VERB N/A
- Revenue Growth
- CODX N/A
- VERB 3125.00
- 52 Week Low
- CODX $0.23
- VERB $3.81
- 52 Week High
- CODX $2.23
- VERB $27.14
- Technical
- Relative Strength Index (RSI)
- CODX 42.29
- VERB 50.28
- Support Level
- CODX $0.27
- VERB $6.61
- Resistance Level
- CODX $0.30
- VERB $8.30
- Average True Range (ATR)
- CODX 0.02
- VERB 0.61
- MACD
- CODX 0.00
- VERB -0.02
- Stochastic Oscillator
- CODX 22.00
- VERB 38.09
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
About VERB Verb Technology Company Inc.
Verb Technology Co Inc leader in interactive video-based sales applications, transforms how businesses attract and engage customers. VERB's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. The segments of the company are MARKET.live and Go Fund Yourself, and it derives maximum revenue from MARKET.live segment.